N/A
N=199
Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail
Alcohol Drinking · Marijuana Smoking
Bottom Line
View on ClinicalTrials.gov: NCT00506753 ↗Enrolled (actual)
199
Serious AEs
0.0%
Results posted
May 2019
Primary outcome: Primary: Alcohol Use, Average # of Drinks Per Week — 11.16; 10.62; 5.16; 3.86 average # of drinks per week
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- MI/CBT (Behavioral); RT/SU (Behavioral)
- Age
- Pediatric, Adult · 14+ yrs
- Sex
- All
- Sponsor
- University of Rhode Island
- Primary completion
- Sep 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Alcohol Use, Average # of Drinks Per Week |
11.16; 10.62; 5.16; 3.86; 7.08; 3.57 | — |
| PRIMARY Marijuana Use |
5.84; 4.98; 2.52; 2.48; 2.48; 2.95 | — |
| PRIMARY Crime: General Predatory Aggression |
6.35; 1.92; 2.13; 1.92; 1.89; 1.44 | — |
Summary
This study will focus on treating substance abusing incarcerated teens using individually administered Motivational Interviewing (MI) followed by group Cognitive Behavior Therapy (CBT). The control group receives individualized Relaxation Training (RT) followed by group Treatment as Usual (TU). Currently, there is little research regarding effective group treatments for incarcerated teens and this study will address this gap in our knowledge base. We seek to reduce substance use and associated risky behaviors post-release (including driving under the influence, risky sexual behaviors, etc.)
Eligibility Criteria
Inclusion Criteria
- Adolescents will be eligible if in the year prior to incarceration they either a) drank alcohol or used marijuana at least once per month or b) binge-drank (> 5 for boys, > 4 for girls) during any two week period; or they drank or used marijuana in the four weeks before the offense for which they were incarcerated; or they used alcohol or marijuana in the four weeks before they were incarcerated.
Exclusion Criteria
Those teens sentenced for less than 4 months or greater than 12 months, those who are younger than 14 years or older than 19 years, and those for whom have inability to consent/assent (example, language barrier) are not obtained will be excluded from participation.
Data sourced from ClinicalTrials.gov (NCT00506753). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.